[go: up one dir, main page]

ES2134491T3 - Nuevos compuestos de carbamato y procedimientos para su preparacion. - Google Patents

Nuevos compuestos de carbamato y procedimientos para su preparacion.

Info

Publication number
ES2134491T3
ES2134491T3 ES95931454T ES95931454T ES2134491T3 ES 2134491 T3 ES2134491 T3 ES 2134491T3 ES 95931454 T ES95931454 T ES 95931454T ES 95931454 T ES95931454 T ES 95931454T ES 2134491 T3 ES2134491 T3 ES 2134491T3
Authority
ES
Spain
Prior art keywords
procedures
preparation
carbamate compounds
aryl
new carbamate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95931454T
Other languages
English (en)
Inventor
Yong Moon Choi
Dong Il Han
Kwang Hyouk Lee
Hyung Cheol Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yukong Ltd
Original Assignee
Yukong Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019940023911A external-priority patent/KR0141286B1/ko
Priority claimed from KR1019940023910A external-priority patent/KR0150239B1/ko
Priority claimed from KR1019940023912A external-priority patent/KR0139717B1/ko
Application filed by Yukong Ltd filed Critical Yukong Ltd
Application granted granted Critical
Publication of ES2134491T3 publication Critical patent/ES2134491T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/19—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

MONOCARBAMATO DE (S) - 2 - ARILO - 1,3 - PROPANODIOL Y SU INTERMEDIO CARBAMATO DE (S) - 3 - ACETOXI - 2 - ARILO - PROPANOL, REPRESENTADO POR LAS FORMULAS (I) Y (II), RESPECTIVAMENTE, TIENEN UNA ACTIVIDAD FARMACEUTICA UTIL FRENTE A ENFERMEDADES DEL SISTEMA NERVIOSO CENTRAL INCLUYENDO MIALGIA NERVIOSA, EPILEPSIA Y APOPLEJIA CEREBRAL, EN DONDE, R ES (A), (B), (C), (D), (E), (F), (G), (H), (I) O (J), EN DONDE X ES UN ATOMO DE OXIGENO O UN ATOMO DE AZUFRE; E Y REPRESENTA UN ELEMENTO HALOGENO, TRIFLUOROMETILO, O UN GRUPO ALQUILO BAJO QUE CONTIENE DE UNO A TRES ATOMOS DE CARBONO.
ES95931454T 1994-09-22 1995-09-21 Nuevos compuestos de carbamato y procedimientos para su preparacion. Expired - Lifetime ES2134491T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1019940023911A KR0141286B1 (ko) 1994-09-22 1994-09-22 2-(2-피리딜) 프로판디올로부터 유도되는 신규한 카바메이트 화합물
KR1019940023910A KR0150239B1 (ko) 1994-09-22 1994-09-22 2-페닐-1,3-프로판디올로부터 유도되는 단일카바메이트 화합물
KR1019940023912A KR0139717B1 (ko) 1994-09-22 1994-09-22 피리딜기를 포함하는 신규한 카바메이트 화합물

Publications (1)

Publication Number Publication Date
ES2134491T3 true ES2134491T3 (es) 1999-10-01

Family

ID=27349100

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95931454T Expired - Lifetime ES2134491T3 (es) 1994-09-22 1995-09-21 Nuevos compuestos de carbamato y procedimientos para su preparacion.

Country Status (8)

Country Link
US (1) US5849772A (es)
EP (2) EP0730575B1 (es)
JP (2) JP2809883B2 (es)
CN (3) CN1071315C (es)
CA (1) CA2176968A1 (es)
DE (1) DE69509745T2 (es)
ES (1) ES2134491T3 (es)
WO (2) WO1996009284A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8729107B2 (en) * 2002-12-06 2014-05-20 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
AU2003298034B2 (en) * 2002-12-06 2011-04-21 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2884444A (en) * 1956-01-13 1959-04-28 Carter Prod Inc 2-phenyl-1,3 propane diol dicarbamate
US2937119A (en) * 1959-06-11 1960-05-17 Carter Prod Inc Nu-monosubstituted-2, 2-dialkyl-1, 3-propanediol dicarbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
GB1593541A (en) * 1977-04-05 1981-07-15 Boots Co Ltd Carbamate esters of hydroxyaryl sulphonium salts and methods of regulating plant growth employing them

Also Published As

Publication number Publication date
JPH09500402A (ja) 1997-01-14
CN1135751A (zh) 1996-11-13
CN1135750A (zh) 1996-11-13
CA2176968A1 (en) 1996-03-28
WO1996009284A1 (en) 1996-03-28
DE69509745T2 (de) 1999-12-09
EP0730576A1 (en) 1996-09-11
CN1216858C (zh) 2005-08-31
JP2809883B2 (ja) 1998-10-15
US5849772A (en) 1998-12-15
JP2809884B2 (ja) 1998-10-15
DE69509745D1 (de) 1999-06-24
CN1071315C (zh) 2001-09-19
EP0730575B1 (en) 1999-05-19
EP0730575A1 (en) 1996-09-11
WO1996009283A1 (en) 1996-03-28
CN1332154A (zh) 2002-01-23
JPH09500401A (ja) 1997-01-14

Similar Documents

Publication Publication Date Title
DK0659410T3 (da) Anvendelse af det aktive middel flupirtin til fremstilling af et lægemiddel til bekæmpelse af muskelspændinger
DE68908971D1 (de) Verwendung von physiologisch wirksamen Substanzen zur Herstellung von Medikamenten für Gehirn- und Nervenerkrankungen.
ATE79261T1 (de) Verfahren zur behandlung von magen-darmstoerungen.
DE3579891D1 (de) N-((4,6-dimethoxypyrimidin-2-yl)aminocarbonyl)-3-trifluoromethylpyridin-2-sulfonamide oder salze davon, diese enthaltendes herbizides mittel und verfahren zur herstellung dieser verbindung.
DK0900200T5 (da) Farmaceutiske sammensætninger til forebyggelse og behandling af sygdom i centralnervesystemet
ATE145914T1 (de) Anticonvulsive fructopyranose zyklische sulfate und sulfite
ES2091575T3 (es) Nuevas aril-alquil-(tio)amidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
DE3879873D1 (de) Physiologisch aktive substanzen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
BRPI0408863A (pt) composto, composição farmacêutica, método para tratar doenças, e, uso de um composto.
DK0451654T3 (da) Anvendelse af N-alkylerede 1,4-dihydropyridin-dicarboxylsyreestere som lægemidler, nye forbindelser og fremgangsmåder til deres fremstilling
ES537300A0 (es) Procedimiento para la preparacion de gangliosidos y sus derivados administrables por nebulizacion
ES2134491T3 (es) Nuevos compuestos de carbamato y procedimientos para su preparacion.
ES2134284T3 (es) Pirido-pirimidindionas, procedimiento para su preparacion y su empleo como medicamentos.
ATE33022T1 (de) S-(carbamoyl-phenylselenyl)-derivate von mercaptanen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
EP0330826A3 (de) Verwendung von Pyridin-2-ethern beziehungsweise Pyridin-2-thioethern mit einem stickstoffhaltigen cycloaliphatischen Ring als antidepressiv wirkende Arzneimittel
PT83309B (de) Neue pyrrolo-benzimidazole pyrrolo-benzoxazole und pyrrolo-benzthiazole verfahren zu ihrer herstellung und diese verbindungen enthaltende arneimittel
DK0401707T3 (da) Heterocyclisk forbindelse, et farmaceutisk lægemiddel og fremgangsmåde til fremstilling af disse
DK671087A (da) Anvendelse af 5-aryl-3h-1,2,4-triazol-3-oner som antikonvulsiva
MX5203E (es) Procedimiento para la purificacion de dinitroanilinas por separacion de nitrosaminas
FI874450A7 (fi) Farmaseuttiset valmisteet alkuperältään toiminnallisten ja elimelliste n aivohäiriöiden hoitamiseen.
ATE65778T1 (de) 4-oxo-thiazolidin-2-yliden-acetamid-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel zur bekaempfung von erkrankungen des zentralnervensystems.
AR226737A1 (es) Procedimiento para la sintesis de la n(i-alil-2-pirrolidinil-metil)-2-metoxi-4-amino-5-metilsulfamoil-benzamida,sus sales de amonio cuaternario,sus n-oxidos,y sus isomeros opticos,asi como sus sales de adicion de acidos farmaceuticamente aceptables
ES2191776T3 (es) Composiciones que contienen bismuto y uno o mas agentes antimicrobianos, para la prevencion y tratamiento de trastornos gastrointestinales.
Liu et al. Frontal lobe seizures, frontal cortex, and dissociative states.
Shankar et al. A search for borna virus-specific genome in human nerve tissue by reverse transcriptase polymerase chain reaction (RT-PCR)

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 730575

Country of ref document: ES